United Natural Trading Inc. issued a recall for Wegmans organic dry roasted salted almonds in January because they were mislabeled as cashews on the back.

A previously recalled pancake and waffle mix product from Quaker Oats’ popular Pearl Milling Company brand has now been classified at the U.S. Food and Drug Administration’s highest risk level due to potential allergen exposure.

(Reuters) - A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, the U.S. Food and Drug Administration's website showed on Friday. The resolution comes two months after the health regulator said there was no longer a shortage of Eli Lilly's weight-loss and diabetes drugs.

A bipartisan group of U.S. state and territory attorneys general is pressing the FDA to take prompt action against those threatening public health by marketing counterfeit forms of branded weight loss medications developed by Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY).

Some U.S. Food and Drug Administration scientists have been told to stop using the words "woman," "disabled" and "elderly" in external communications, two sources familiar with the matter said, part of a list of banned terms that a White House spokesman said had misinterpreted President Donald Trump's executive order.

Food and Drug Administration staffers were told not to use words like “woman” and “disabled” in work chats for at least the last week, but the White House said this order was erroneous. A White House spokesperson told Reuters that the list of “prohibited words” came from a misunderstanding of President Donald Trump’s executive orders

Washington: A list of banned words quietly circulated within the U.S. Food and Drug Administration (FDA), restricting terms like "sex," "identity," "women," "diverse," and "elderly" from official use,